Saturday 17 October 2026
Export CUPR’s income statement to Excel — free account
Cuprina Holdings (Cayman) Limited
CUPR Healthcare Medical Instruments & Supplies
Cuprina Holdings (Cayman) Limited’s revenue for fiscal 2025 (year ended December 2025) was $38,800.00, up 9.30% from fiscal 2024.
1.90
0.05
−2.56%
Follow CUPR
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Altman Z-Score |
— | — | (0.96) |
Altman Z″-Score (non-manufacturers) |
— | (32.10) | (2.57) |
P/Operating CF |
— | 0.00 | 0.00 |
P/B ratio |
— | 0.00 | 0.00 |
Price to Tangible BV |
— | 0.00 | 0.00 |
EV/Sales |
— | 0.00 | 0.00 |
EV/EBITDA |
— | 0.00 | 0.00 |
EV/Operating CF |
— | 0.00 | 0.00 |
EV/FCF |
— | 0.00 | 0.00 |
Quick Ratio |
— | 0.04 | 1.08 |
Current Ratio |
— | 0.27 | 2.35 |
Net Debt/EBITDA |
— | (0.06) | 0.57 |
Debt/Assets |
0.00% | 12.55% | 4.38% |
Debt/Equity |
— | (0.05) | 0.07 |
Asset Turnover |
— | 0.06 | 0.01 |
Operating CF/Net income |
— | 0.79 | 1.95 |
Capex/Depreciation |
— | (0.52) | (1.60) |
Interest Coverage |
— | (44.14) | (329.37) |
| — | 0.00% | (1,114.99%) | |
| — | (178.86%) | (92.04%) | |
ROIC |
— | 0.00% | (130.67%) |
Return on Tangible Assets |
— | 36.07% | (108.85%) |
Average Days of Receivables |
— | 902.73 | 1,872.04 |
Research and Development Expense of Revenue |
— | 499.72% | 454.64% |
Selling, General and Administrative Expense of Revenue |
— | 2,900.85% | 9,221.39% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% |
Graham Net Nets |
— | 0.00 | 0.00 |
Graham Number |
— | 0.00 | 0.00 |
Free Cash Flow per Share |
— | (0.41) | (2.79) |
Cash per Share |
— | 0.04 | 0.95 |
Shareholders Equity per Share |
— | (1.46) | 1.54 |
Interest Debt per Share |
— | 0.00 | 0.00 |
Book value per Share |
— | (1.46) | 1.54 |
Free Cash Flow |
— | (0.92) | (7.15) |
Working Capital |
— | (3.22) | 3.28 |
Capital Expenditures |
— | (0.02) | (0.05) |
Net Current Asset Value |
— | (3.34) | 3.02 |
EV/EBIT |
— | 0.00 | 0.00 |
Capex to Sales |
— | 0.45 | 1.17 |
| Other line items | |||
Depreciation/Fixed assets |
— | 0.73 | 0.47 |
Cash ROIC |
— | 30.50% | (107.57%) |
Accounts Receivable Turnover |
— | 0.00 | 0.27 |
Accounts Payable Turnover |
— | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 8.36 |
Days of Inventory on Hand |
— | 12.59 | 0.00 |
Revenue per Share |
— | 0.02 | 0.02 |
Operating CF per Share |
— | (0.40) | (2.77) |
Capex per Share |
— | (0.01) | (0.02) |
Average Receivables |
— | — | 0.14 |
Average Assets |
— | 0.64 | 3.95 |
Average Common Equity |
— | — | 0.33 |
Columns are period end dates